Established by Dr. Uri Arny in 2005, ARDS deals with the development, manufacturing and marketing of innovative dental implants. ARDS’ guiding philosophy has inspired the company to develop a unique drilling technique which causes minimum damage to the bone and maximizes the primary stabilization of the implants once put in it. ARDS holds a number of international patents regarding:
- The shape of the implant's surface.
- A simple, bone preserving drilling technique.
- A unique implant designed for thin ridges.
ARDS’ aspiration for perfection is conveyed in the following ways:
- A shorter healing phase - immediate implant after extraction.
- The use of implants also in problematic areas.
- A user-friendly, simply assigned implant process.
The main advantages of ARDS' drilling and implanting process:
- Saving 40% of the bone by reducing the amount of drilled bone.
- Significantly shortening the process of bone-implant integration due to a unique design of the implant which increases bone-implant contact in the surgery phase (in comparison with conventional implants of the same diameter).
- A drilling method combined with the shape of the implant which results in the compression of the spongyosal bone around the apical part of the implant during its insertion. Thus, the forces are dispersed along the entire implant and not only at its upper part, as in common implants held only at the cortical bone at the end of the implant.
- The drilling method enables precise control over the placement and shape of the bore hole. This is attainable by the usage of leading pins which direct the drill at the correct angle throughout the process and stabilize it, also in thin ridges.
ARDS’ management's main office is situated in Rishon-Le-Zion, Israel. Manufacturing and packaging supervised processes are being done at ARDS' production plant located at Teffen industrial park, Israel.
Osseointegration is needed in order to create a durable stabilization of the implant in the bone. In order to intensify the osseointegration, two processes are required:
The first phase is sand blasting the implant in order to create a rougher surface area. Generally, cells adhere better onto rough surfaces. The deep pits created by the blasting procedure, act as retentive pockets for newly formed bone.
The second phase is coating the implant using bioactive Calcium-Phosphate.
The sponge-like micro structure of this coating induces an intense capillary effect for blood and tissue fluids. Thereby it develops the ambient conditions for the increased adhesion of the osteoinductive factors contained in these fluids.
In addition, the position of the Ca-Ph crystals towards the implant’s surface immobilizes the cells responsible for the bone formation. The result is an expedited osseointegration process (occurring 14-30 days following the implantation).
The coating is completely resorbed in the bone 6-12 weeks after the implantation.
Type of Titanium
ARDS implants are composed of medical titanium alloy Ti-6 AL-4V which retains all manufacturing regulations.
Manufacturing
ARDS' implants and reconstruction parts are manufactured at the company's production plant, situated at Teffen industrial park in the north part of Israel. The plant retains a quality control system and regulations of the highest required level in accordance with the most severe international approvals.
Approval & Certificates
ARDS holds the approvals of ISO 9001, ISO 13485, of European body CE, Israeli AMAR and American FDA.
